We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Hydrogel-based nanoparticles: revolutionizing brain tumor treatment and paving the way for future innovations
Summary
Researchers reviewed how nanoparticles embedded in hydrogels — water-based gel materials — can serve as targeted drug delivery vehicles for brain tumors by crossing the blood-brain barrier, a major obstacle that blocks most medications from reaching the brain. These systems have shown improved survival rates in studies, and the review outlines remaining challenges around manufacturing, stability, and scaling up for clinical use.
Brain tumor treatment remains a significant challenge due to their high mortality and resistance to current therapies. This paper discusses the promising potential of hydrogel-based nanoparticles as innovative drug delivery systems for brain tumor therapy. Extensive characterization techniques reveal the ability of these Nano-systems to demonstrate prolonged blood circulation and targeted delivery, leading to improved survival rates. Designed with optimized physicochemical characteristics, these nanoparticles effectively cross the blood-brain barrier, circumventing a major impediment to drug delivery to the brain. By delivering drugs directly to the tumor bed, these nanoparticles enhance therapeutic outcomes and minimize adverse effects. In addition, this review investigates the techniques for characterizing, visualizing, and modifying these nanoparticles, as well as the standing challenges and promising research avenues for their clinical application. Further investigations are encouraged by this review to investigate potential advancements in hydrogel-based nanoparticle therapeutic approaches for brain tumors. This includes investigating tailored hydrogels, hybrid systems, computational modeling, and the integration of gene therapy and immunotherapy techniques. The study also addresses the need for enhanced synthesis techniques, stability, scalability, and cost-cutting measures to overcome obstacles and advance the clinical use of hydrogel-based nanoparticles in treating brain tumors.
Sign in to start a discussion.
More Papers Like This
Application of Hydrogel as Drug Carrier in Tumor Therapy
This review summarizes recent advances in hydrogel-based drug delivery systems for cancer therapy, focusing on their ability to achieve controlled drug release and respond to tumor microenvironment signals for targeted treatment.
A Physiological Microfluidic Blood–Brain‐Barrier Model for In Vitro Study of Nanoparticle Trafficking and Accumulation
Researchers developed a microfluidic blood-brain barrier model using human endothelial cells, astrocytes, and pericytes to compare nanoparticle transport, finding that extracellular vesicles crossed most efficiently and that ligand presentation and membrane composition — not size or stiffness — were the primary determinants of barrier penetration.
Nanoparticles in Drug Delivery
This review examines how nanoparticles made from various materials, including polymers, are being developed for targeted drug delivery across biological barriers. Researchers highlighted advances in stimuli-responsive nanoparticle engineering for tumor targeting and the integration of AI models for personalized medicine. While focused on biomedical applications, the study is relevant to understanding how polymer-based particles interact with biological systems at the nanoscale.
The Other Side of Plastics: Bioplastic-Based Nanoparticles for Drug Delivery Systems in the Brain
This review explores bioplastic-based nanoparticles as potential drug delivery vehicles for brain diseases, examining both their therapeutic promise and safety concerns. Researchers found that biodegradable polymers can pass through biological barriers and concentrate in specific tissues, making them useful for targeted drug delivery. However, the study cautions that the same properties enabling tissue penetration also raise concerns about long-term accumulation and unknown biological effects.
A physiological microfluidic blood-brain-barrier model for in vitro study of nanoparticle trafficking and accumulation
Researchers developed a physiological microfluidic blood-brain barrier model using human brain endothelial cells in direct contact with astrocytes and pericytes in an extracellular matrix. They used the model to study how nanoparticles including nanoplastics traffic across the barrier, finding that particle type and size influenced transcytosis rates.